Martin Gerstel has served as Compugen's chairman of the Board of Directors since 1997, other than from February 2009 to February 2010, when he served as either CEO or co-CEO and, in both cases, as a member of the Board. Prior to Compugen, he was co-chairman and CEO of ALZA Corporation, which he helped found in 1968 and was a director of various public and private companies in the US. Currently, in addition to his role as active chairman at Compugen, Mr. Gerstel is the chairman of Evogene Ltd., Keddem Bioscience, and the co-founder and co-chairman of Itamar Medical. He is a member of the Board of Governors and the Executive Committee of the Weizmann Institute of Science and a director of Yeda, its technology licensing affiliate. Mr. Gerstel holds a BSc from Yale University and an MBA from Stanford University.